Regeneron Pharmaceuticals, Inc. (REGN) Tops Q2 EPS by 81c

August 6, 2013 6:51 AM EDT
Get Alerts REGN Hot Sheet
Price: $534.27 -0.68%

EPS Growth %: +49.8%

Financial Fact:
Net loss: 264.8M

Today's EPS Names:
More
Trade Now! 
Join SI Premium – FREE
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) reported Q2 EPS of $1.73, $0.81 better than the analyst estimate of $0.92. Revenue for the quarter came in at $458 million versus the consensus estimate of $470.63 million.

For earnings history and earnings-related data on Regeneron Pharmaceuticals, Inc. (REGN) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings